These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3954390)

  • 1. Woronoff ring during anthralin therapy for psoriasis.
    Gupta AK; Ellis CN; Goldfarb MT; Voorhees JJ
    Arch Dermatol; 1986 Mar; 122(3):248. PubMed ID: 3954390
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reduction of erythema by the addition of bituminous coal tar in anthralin short-term therapy].
    Heller G
    Dermatol Monatsschr; 1985; 171(11):718-20. PubMed ID: 4085670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
    Puschmann M
    Z Hautkr; 1983 Nov; 58(22):1646-7. PubMed ID: 6659639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of various kinds of tar and tar concentrations on anthralin erythema].
    Wemmer U; Schulze HJ; Mahrle G; Steigleder GK
    Z Hautkr; 1986 Jun; 61(12):849-52. PubMed ID: 3751210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between skin type and erythemal response to anthralin.
    Maurice PD; Greaves MW
    Br J Dermatol; 1983 Sep; 109(3):337-41. PubMed ID: 6615720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppression of cignolin-induced erythema by tar].
    Schulze HJ
    Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Suppression of dithranol erythema by the addition of tar in short-term therapy].
    Wozel G; Barth J
    Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Potential factors influencing dithranol erythema].
    Richter G; Barth J
    Dermatol Monatsschr; 1986; 172(5):272-5. PubMed ID: 3721033
    [No Abstract]   [Full Text] [Related]  

  • 9. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthralin inflammation versus UV-erythema in psoriatics.
    Schauder S; Mahrle G
    Br J Dermatol; 1983 Jul; 109 Suppl 25():117-9. PubMed ID: 6860579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicologic study of anthralin in an aqueous cream formulation.
    Neill SM; Bugrein A; Coulson IH; Greaves MW
    Cutis; 1984 Dec; 34(6):563-6. PubMed ID: 6518819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperreactivity to dithranol--irritation or allergy?].
    Lohrisch I; Haustein UF; Neumann JH
    Dermatol Monatsschr; 1986; 172(5):266-71. PubMed ID: 3721032
    [No Abstract]   [Full Text] [Related]  

  • 13. Short contact anthralin in the treatment of psoriasis: a study of different contact times.
    MacDonald KJ; Marks J
    Br J Dermatol; 1986 Feb; 114(2):235-9. PubMed ID: 3947539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsoriatic therapy and skin cancer.
    Briffa DV
    Br J Dermatol; 1981 Aug; 105 Suppl 20():70. PubMed ID: 7284271
    [No Abstract]   [Full Text] [Related]  

  • 15. Anthralin therapy for psoriasis. A new look at an old compound.
    Gorsulowsky DC; Voorhees JJ; Ellis CN
    Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical treatment of psoriasis with dithranol.
    Farber EM
    Acta Derm Venereol Suppl (Stockh); 1984; 112():11-6. PubMed ID: 6596820
    [No Abstract]   [Full Text] [Related]  

  • 17. Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
    Mustakallio KK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():23-7. PubMed ID: 6169361
    [No Abstract]   [Full Text] [Related]  

  • 18. The effectiveness of low-strength anthralin in psoriasis. A paired comparison study.
    Marley WM; Hernandez AD; Josephs JA; Dawkins L
    Arch Dermatol; 1982 Nov; 118(11):906-8. PubMed ID: 7138048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
    Brun P; Juhlin L; Schalla W
    Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritancy of anthralin in patients with psoriasis and widespread vitiligo.
    Roberts DL
    Br J Dermatol; 1984 Feb; 110(2):247-8. PubMed ID: 6696841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.